Dynavax Technologies



Ebitda Alterar Data
AbbVie USD 6.92B 258M 2024-12
Adma Biologics USD 40.41M 1.17M 2024-12
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.26B 597M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Dynavax Technologies USD 439K 11.7M 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Glaxosmithkline GBP 1.69B 1.6B 2024-12
Merck USD 7.12B 1.06B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
TG Therapeutics USD 29.96M 12.91M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Dynavax Technologies - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.